Company description
Founded in 2017, Cutaneous NeuroDiagnostics (CND) is the only commercial diagnostic laboratory specializing in the detection of neurodegenerative disease, particularly synucleinopathy, small fiber neuropathy and amyloidosis, through the examination of skin tissue. CND offers medical practitioners and their patients objective evidence to aid in the diagnosis of the potential underlying neurological disease
